Publications with impact factor
2024
Domecky P, Rejman Patkova A, Zaloudkova L, Kucera T, Sponer P, Maly J. Rethinking risk prediction: The role of albumin and other parameters in implant-associated complications after hip or knee arthroplasty. PLoS One. 2024;19(7):e0306468. IF2023: 2,9 (IF Q1)
Hajduchova H, Cerveny M, Brabcova I, Chloubova I, Prokesova R, Maly J, Dosedel M, Tesar O, Vlcek J, Tothova V. Medication administration errors in the selected Czech hospitals: An observational study. Pielegniarstwo XXI Wieku. 2024; 23(1):36-40. IF2023: 0.2 (IF Q4)
Krakorova G, Domecky P, Blazek J, Pesek M, Venclicek O, Havel L, Hrnciarik M, Krejci J, Mullerova A, Marel M, Duba J, Svaton M. Omission of staging PET/CT linked to reduced survival in stage III non-small cell lung cancer: insights from the LUCAS project real-world data. Transl Lung Cancer Res 2024;13(7):1495-1504. IF2023: 4.0 (IF Q1)
Ocovska Z, Prochazkova J, Marikova M, Vlcek J. Renal drug dosage adjustments and adverse drug events in patients with chronic kidney disease admitted to the hospital: a cross-sectional study. Expert Opin Drug Saf. 2024 Feb 8; 23(4):457-467. IF2023: 3.0 (IF Q2)
Svaton M, Knetki-Wroblewska M, Tabor S, Domecky P, Venclicek O, Krejci J, et al. Impact of PD-L1 Expression on the Overall Survival of Patients With Non-small Cell Lung Cancer Treated With Single-agent Pembrolizumab. In Vivo. IF 2023: 1,8 (IF Q3)
2023
Brabcova I, Hajduchova H, Tothova V, Chloubova I, Cerveny M, Prokesova R, Maly J, Vlcek J, Dosedel M, Mala-Ladova K, Tesar O, O'Hara S. Reasons for medication administration errors, barriers to reporting them and the number of reported medication administration errors from the perspective of nurses: A cross-sectional survey. Nurse Educ Pract. 2023 Apr 11;70:103642. IF2022: 3.2 (IF Q1)
Cerveny M, Hajduchova H, Brabcova I, Chloubova I, Prokesova R, Maly J, Mala-Ladova K, Dosedel M, Tesar O, Vlcek J, Tothova V. Self-reported medication administration errors in clinical practice of nurses: a descriptive correlation study. Med Pr. 2023 May 19;74(2):85-92. IF2022: 1.0 (IF Q4)
Cvrcek J, Kubena AA, Jor T, Nanka O, Drtikolova Kaupova S, Veleminsky P. Does sternal body shape reflect family relationships? A study on a genealogically documented Central European osteological sample (19th-20th centuries). Anat Rec (Hoboken). 2023 Feb;306(2):366-377. IF2022: 2.0 (IF Q2)
Denhaerynck K, Dobbels F, Kostalova B, De Geest S; BAASIS Consortium. Psychometric Properties of the BAASIS: A Meta-analysis of Individual Participant Data. Transplantation. 2023 Aug 1;107(8):1795-1809. IF2022: 6.2 (IF Q1)
Domecky P, Rejman Patkova A, Mala‑Ladova K, Maly J. Infammatory blood parameters as prognostic factors for implant-associated infection after primary total hip or knee arthroplasty: a systematic review. BMC Musculoskeletal Disorders. 2023;24:383. IF2022: 2.3 (IF Q2)
Ecsiova D, Kamaradova K, Nova M, Hoffmann P, Rozsivalova P, Simkovic M, Zak P. Pulmonary damage in a patient with hairy cell leukemia - infectious involvement or hematological disease activity? Case report. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Dec;167(4):385-389. IF2022: 0.9 (IF Q4)
Karesova I, Simko J, Fekete S, Zimcikova E, Malakova J, Zivna H, Pavlikova L, Palicka V. The Effect of Zonisamide on Rat Bone Mass, Structure, and Metabolism. Pharmacology. 2023;108(4):359-367. doi: 10.1159/000529970. Epub 2023 May 22 IF2022: 3.1 (IF Q3)
Kubes R, Stollin M, Magersky S, Bobelyak M, Vaculik J, Vcelak J, Kubena AA, Louzil J, Salaj P. Predicting the development of hemophilic arthropathy in patients with hemophilia based on patient age: a retrospective single-center database study. Expert Rev Hematol. 2023 Jul-Dec;16(12):1099-1105. IF2022: 2.8 (IF Q3)
Moudallel S, van den Eynde C, Maly J, Rydant S, Steurbaut S. Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance. Naunyn Schmiedebergs Arch Pharmacol. 2023 Jun;96(6):1143-1153. IF2022: 3.6 (IF Q2)
Ocovska Z, Marikova M, Vlcek J. Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study. Front Pharmacol. 2023 Feb 2;14:1088900. IF2022: 5.6 (IF Q1)
Pulkrabkova L, Muckova L, Hrabinova M, Sorf A, Kobrlova T, Jost P, Bezdekova D, Korabecny J, Jun D, Soukup O. Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity. Arch Toxicol. 2023 Aug;97(8):2209-221. IF2022: 6.1 (IF Q1)
Singh RB, Nabavizadeh F, Fedacko J, Pella D, Vanova N, Jakabcin P, Fatima G, Horuichi R, Takahashi T, Mojto V, Juneja L, Watanabe S, Jakabcinova A. Dietary Approaches to Stop Hypertension via Indo-Mediterranean Foods, May Be Superior to DASH Diet Intervention. Nutrients. 2022 Dec 22;15(1):46. IF2022: 5.9 (IF Q1)
Urbańczyk K, Guntschnig S, Antoniadis V, Falamic S, Kovacevic T, Kurczewska-Michalak M, Miljković B, Olearova A, Sviestina I, Szucs A, Tachkov K, Tiszai Z, Volmer D, Wiela-Hojeńska A, Fialova D, Vlcek J, Stuhec M, Hogg A, Scott M, Stewart D, Mair A, Ravera S, Lery FX, Kardas P. Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Front Pharmacol. 2023 Aug 2;14:1244151. IF2022: 5.6 (IF Q1)
Visek J, Ryskova L, Machacova A, Marikova M, Blaha V. In vitro comparison of the effectiveness of various antimicrobial locks with taurolidine in the treatment and prevention of catheter-related bloodstream infections in patients receiving parenteral nutrition. Nutrition. 2023 Oct;114:112115. IF2022: 4.4 (IF Q2)
Zavrelova A, Sima M, Malakova J, Rozsivalova P, Paterova P, Zak P, Visek B, Michalickova D, Slanar O, Radocha J. Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug-resistant Pseudomonas aeruginosa infections in cancer patients. Br J Clin Pharmacol. 2023 Apr;89(4):1452-1461. IF2022: 3.4 (IF Q2)
2022
Hendrychova T, Svoboda M, Maly J, Vlcek J, Zimcikova E, Dvorak T, Zatloukal J, Volakova E, Plutinsky M, Brat K, Popelkova P, Kopecky M, Novotna B, Koblizek V. Self-reported overall adherence and correct inhalation technique discordance in COPD population. Front Pharmacol. 2022 Aug 12;13:860270. IF2021: 5.988 (IF Q1)
Jakabcin P, Kello M, Zan J, Kolar J, Ulicny J. Hetastarch induced volume changes of starving adenoma and suggested mechanism of action. Sci Rep. 2022 Oct 26;12(1):17988. IF2021: 4.977 (IF Q2)
Janousek J, Pilarova V, Macakova K, Nomura A, Veiga-Matos J, Silva DDD, Remião F, Saso L, Mala-Ladova K, Maly J, Novakova L, Mladenka P. Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites. Crit Rev Clin Lab Sci. 2022 Dec;59(8):517-554. IF2021: 7.721 (IF Q1)
Kardas P, Bago M, Barnestein-Fonseca P, Garuoliene K, Granas AG, Gregorio J, Hadžiabdic MO, Kostalova B, Leiva-Fernandez F, Lewek P, Mala-Ladova K, Schneider MP, Van Boven JFM, Volmer D, Ziampara I, Agh T. Reimbursed medication adherence enhancing interventions in 12 European countries: current state of the art and future challenges. Front Pharmacol. 2022 Aug 11;13:944829. IF2021: 5.988 (IF Q1)
Kostalova B, Mala-Ladova K, Dusilova Sulkova S, Denhaerynck K, De Geest S, Maly J. Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication nonadherence. Front Pharmacol. 2022 Oct 13;13:973564. IF2021: 5.988 (IF Q1)
Nabergoj Makovec U, Goetzinger C, Ribaut J, Barnestein-Fonseca P, Haupenthal F, Herdeiro MT, Grant SP, Jácome C, Roque F, Smits D, Tadic I, Dima AL; European Network to Advance Best Practices and TechnoLogy on Medication AdherencE (ENABLE) - Mala-Ladova K, Vlcek J. Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study. BMJ Open. 2022 Apr 22;12(4):e059674. IF2021: 3.006 (IF Q2)
Ocovska Z, Marikova M, Koci J, Vlcek J. Drug-related Hospital Admissions via the Department of Emergency Medicine: A Cross-sectional Study from the Czech Republic. Front Pharmacol. 2022 Jun 13;13:899151. IF2021: 5.988 (IF Q1)
Singh RB, Fedacko J, Pella D, Fatima G, Elkilany G, Moshiri M, Hristova K, Jakabcin P, Vaňova N. High Exogenous Antioxidant, Restorative Treatment (Heart) for Prevention of the Six Stages of Heart Failure: The Heart Diet. Antioxidants (Basel). 2022 Jul 27;11(8):1464. IF2021: 7.675 (IF Q1)
2021
Domecky P, Rejman Patkova A, Mala-Ladova K, Maly J. Inflammatory blood parameters as prognostic factors for surgical site infection after primary hip or knee arthroplasty: a systematic review protocol. BMJ Open. 2021 Sep 21;11(9):e046027. IF2020: 2.692 (Q2)
Dosedel M, Jirkovsky E, Macaková K, Krcmova LK, Javorska L, Pourova J, Mercolini L, Remião F, Novakova L, Mladenka P, On Behalf Of The Oemonom. Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination. Nutrients. 2021;13(2):615. IF2020: 5.719 (Q2)
Dvorackova S, Mala-Ladova K, Zimcikova E, Jirsova E, Steurbaut S, Kubena AA, Kolar J, Maly J. Spontaneous reports of adverse drug reactions related to oral anticoagulants in the Czech Republic. Int J Clin Pharm. 2021;43(4):948-957. IF2020: 2.054 (Q3)
Grega D, Ambrus T, Matejovic A, Sutorova M, Kolar J. Analysis of the effectiveness of the pharmacy network. Farmacia. 2021;69(4):799-805. IF2020: 1.433 (Q4)
Hloch K, Dosedel M, Tebbens JD, Zaloudkova L, Medkova H, Vlcek J, Soukup T, Pavek P. Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment. Front Pharmacol. 2021 Nov 5;12:703279. IF2020: 5.811 (Q1)
Kostalova B, Mala-Ladova K, Kubena AA, Horne R, Dusilova Sulkova S, Maly J. Changes in Beliefs About Post-Transplant Immunosuppressants Over Time and Its Relation to Medication Adherence and Kidney Graft Dysfunction: A Follow-Up Study. Patient Prefer Adherence. 2021 Dec 31;15:2877-2887. IF2020: 2.711 (Q2)
Kostalova B, Ribaut J, Dobbels F, Gerull S, Mala-Ladova K, Zullig LL, De Geest S. Medication adherence interventions in transplantation lack information on how to implement findings from randomized controlled trials in real-world settings: A systematic review. Transplant Rev (Orlando). 2021 Nov 2;36(1):100671. IF2020: 3.943 (Q2)
Marikova M, Ocovska Z, Nerad V, Kubena AA, Blaha V, Vlcek J. Hospital admissions to geriatric ward related to adverse drug events: a cross-sectional study from the Czech Republic. Int J Clin Pharm. 2021;43(5):1218-1224. IF2020: 2.054 (Q3)
2020
Austin PD, Joskova V, Patkova A, Elia M. Contribution of intravenous medication to water and sodium intake in upper and lower gastrointestinal surgical patients. Nutrition. 2020 Apr 6;78:110808. IF2019: 3.639 (Q2)
da Costa FA, Mala-Ladova K, Lee V, Tous S, Papastergiou J, Griffiths D, Chaumais MC, Hersberger KE, Viola R, Paulino E, Lobban T, Neubeck L, Freedman B, Antoniou S. Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross‑sectional study. J Thromb Thrombolysis. 2020;49(4):606-17. IF2019: 2.054 (Q3Q2Q3)
Dolezil D, Markova J, Klimes J, Pocikova Z, Dostal F, Stepanova R, Svobodnik A. An Investigation into the Prevalence of Migraine and Its Prophylactic Treatment Patterns in the Czech Republic: An Observational Study. J Pain Res. 2020;13:2895-906. IF2019: 2.386 (Q3)
Chalupa R, Babica J, Nesmerak K. History of teaching of pharmacy at the faculty of science of the Charles University In 1920–1950. Chem Listy. 2020;114(9):578-85. IF2019: 0.39 (Q4)
Chalupa R, Babica J, Nesmerak K. Pharmacists, Chemistry and Faculty of Science of Charles University. Chem Listy. 2020;114(10):635-43. IF2019: 0.39 (Q4)
Maly J, Dosedel M, Kubena AA, Mala-Ladova K, Vosatka J, Brabcova I, Hajduchova H, Bartlova S, Tothova V, Vlcek J. Analysis of the fall-related risk of pharmacotherapy in Czech hospitals: A case control study. J Eval Clin Pract. 2020;26(3):973-82. IF2019: 1.681 (Q3)
Mohos V, Fliszár-Nyúl E, Lemli B, Zsidó BZ, Hetényi C, Mladenka P, Horky P, Pour M, Poór M. Testing the Pharmacokinetic Interactions of 24 Colonic Flavonoid Metabolites with Human Serum Albumin and Cytochrome P450 Enzymes. Biomolecules. 2020 Mar 6;10(3):409. IF2019: 4.082 (Q4)
Nesmerak K, Kudlacek K, Kozlik P, Sticha M, Kozlik P, Vasickova P, Babica J. Long-term stability of alkaloids in solid dosage forms. Chem Listy. 2020;114(1):52-7. IF2019: 0.39 (Q4)
Soukup T, Hloch K, Dosedel M, Tebbens JD, Nekvindova J, Sembera S, Veleta T, Pavek P, Barvik I. The influence of coffee intake and genetics on adenosine pathway in rheumatoid arthritis. Pharmacogenomics. 2020 Jul;21(11):735-49. IF2019: 2.339 (Q2)
2019
Brabcova I, Hajduchova H, Tothova V, Bartlova S, Filka J, Dosedel M, Maly J, Vlcek J. Selected Risk Factors of Falls in Hospitalized Patients: A Case-Control Study. Neuro Endoctinol Lett. 2019 Feb;39(7):481-8. IF2018: 0.698 (Q4)
Connors JM, Gregor S, Crandall D, Netuka I, Mehra MR. Low-intensity anti-coagulation using Vitamin K antagonists and Factor X activity: A validation analysis of the MAGENTUM-1 study. J Heart Lung Transplant. 2019;38(6):668-9. IF2018: 8.578 (Q1) (letter)
Dvorackova E, Pavek P, Kovacova B, Rychlickova J, Suchopar O, Hojny M, Tebbens JD, Vlcek J. Is Computer-Assisted Aminoglycoside Dosing Managed by a Pharmacist a Safety Tool of Pharmacotherapy? Physiol Res 2019;68 (Suppl 1):S87-S96. IF2018: 1.701 (Q4)
Dvorackova E, Rychlickova J, Pavek P, Hojny M, Vlcek J. Analysis and management of drug related problems on a nephrology ward from a pharmacist's point of view. Pharmazie. 2019 Oct 1;74(10):625-29. IF2018: 0.820 (Q3)
Fialova D, Laffon B, Marinkovic V, Tasic L, Doro P, Soos G, Mota J, Dogan S, Brkic J, Teixeira JP, Valdiglesias V, Costa S, EUROAGEISM H2020 project and WG1b group "Healthy clinical strategies for healthy aging" of the EU COST Action IS 1402. Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies). Eur J Clin Pharmacol. 2019 Apr;75(4):451-66. IF2018: 2.774 (Q1)
Maly J, Zimcikova E, Babica J, Kubena AA, Kostriba J, Mala-Ladova K. Representative sample survey on factors determining the Czech physicians’ awareness of generic drugs and substitution. BMC Health Serv Res. 2019;19(1):777. IF2018: 1.932. (Q2)
Maly J, Dvorackova S, Zimcikova E, Kubena AA, Kolar J, Vlcek J, Penka M, Mala-Ladova K. Patterns in anticoagulant utilization in the Czech Republic during 2007-2017. J Thromb Thrombolysis. 2019 Feb;47(2):305-11. IF2018: 2.941 (Q3Q2Q3)
Maly J, Dosedel M, Vosatka J, Mala-Ladova K, Kubena AA, Brabcova I, Hajduchova H, Bartlova S, Tothova V, Vlcek J. Pharmacotherapy as major risk factor of falls – analysis of 12 months experience in hospitals in South Bohemia. J Appl Biomed. 2019;17(60):53-60. IF2018: 1.573 (Q3)
Migkos T, Applova L, Horky P, Tvrdy V, Karlickova J, Macakova K, Hrubsa M, Catapano MC, Tomanek M, Pour M, Mladenka P. The influence of microbial isoflavonoid specific metabolites on platelets and transition metals iron and copper. Phytomedicine. 2019;62:152974. IF2018: 4.180 (Q2)
Nesmerak K, Kudlácek K, Sticha M, Kozlik P, Babica J. HPLC–MS/MS analysis of degradation products of neosalvarsan in a 76-year-old injection preparation. Monatsh Chem. 2019;150(9):1611-15. IF2018: 1.501 (Q3)
Pokladnikova J, Stefancikova M, Haviger J, Bishop FL, Wang B, Guan X, Musil F. Effect of expectation on short- and long-term treatment response to Acupuncture in migraine patients. Eur J Integr Med. 2019 Feb;26:31-6. IF2018: 0.948 (Q4)
Vytrisalova M, Hendrychova T, Touskova T, Zimcikova E, Vlcek J, Nevoranek L, Svoboda M, Hejduk K, Brat K, Plutinsky M, Novotna B, Musilova P, Cernohorsky M, Koblizek V. Breathing Out Completely Before Inhalation: The Most Problematic Step in Application Technique in Patients With Non-Mild Chronic Obstructive Pulmonary Disease. Front Pharmacol. 2019;10:241. IF2018: 3.845 (Q1)
2018
Baudischova L, Straznicka J, Pokladnikova J, Jahodar L.The quality of information on the internet relating to top-selling dietary supplements in the Czech Republic. Int J Clin Pharm. 2018;40(1),183-189. IF2017: 1.508
Kamekis A, Bertsias A, Moschandreas J, Petelos E, Papadakaki M, Tsiantou V, Saridaki A, Symvoulakis EK, Souliotis K, Papadakis N, Faresjo T, Faresjo A, Martinez L, Agius D, Uncu Y, Sengezer T, Samoutis G, Vlcek J, Abasaeed A, Merkouris B, Lionis C. Patients’ intention to consume prescribed and non-prescribed medicines: A study based on the theory of planned behaviour in selected European countries. J Clin Pharm Ther. 2018 Feb;43(1):26-35. IF2017: 1.661
Karesova I, Simko J, Fekere S, Zimcikova E, Malakova J, Zivna H, Pavlikova L, Palicka V. The effect of levetiracetam on rat bone mineral density, bone structure and biochemical markers of bone metabolism. Eur J Pharmacol. 2018 Apr 5;824:115-119. IF2017: 3.040
Kudlacek K, Nesmerak K, Sticha M, Kozlik P, Babica J. Degradation of ouabain in 80-year-old injection solution studied by HILIC–MS. Monatsh Chem. 2018;149(9):1555-1560. IF2017: 1.285
Musil F, Pokladnikova J, Pavelek Z, Wang B, Guan X, Valis M. Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial. Neuropsychiatr Dis Treat. 2018 May 10;14:1221-1228. IF2017: 2.195
Pokladnikova J, Maresova P, Dolejs J, Park AL, Wang B, Guan X, Musil F. Economic analysis of acupuncture for migraine prophylaxis. Neuropsychiatr Dis Treat. 2018;14:3053-3061. IF2017: 2.195
Vankova B, Mala-Ladova K, Kubena AA, Maly J, Dusilova Sulkova S. Immunosuppressive therapy related adherence, beliefs and self-management in kidney transplant outpatients. Patient Pref Adher. 2018;12:2065-2613. IF2017: 1.733
2017
Belkina T, Duvanova N, Karbovska J, Tebbens JD, Vlcek J. Antibiotic use practices of pharmacy staff: a cross-sectional study in Saint Petersburg, the Russian Federation. BMC Pharmacol Toxico. 2017 Feb 14;18(1): Art. No. 11. IF2016: 2.288
Kudlacek K, Nesmerak K, Sticha M, Kozlik P, Babica J. Historical injection solutions of quinine analyzed by HPLC/MS. Monatsh Chem. 2017;148(9):1613-1618. IF2016: 1.282
Meincke R, Pokladnikova J, Straznicka J, Meyboom RHB, Niedrig D, Russmann S, Jahodar L. Allergy-like immediate reactions with herbal medicines in children: A retrospective study using data from VigiBase®. Pediatr Allergy Immunol. 2017 Nov;28(7):668-674. IF2016: 2.676
Mlčoch T, Klimeš J, Fila L, Vávrová V, Skalická V, Turnovec M, Krulišová V, Jirčíková J, Zemková D, Dědečková KV, Bílková A, Frühaufová V, Homola L, Friedmannová Z, Drnek R, Dřevínek P, Doležal T, Macek M Jr. Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study. Eur J Health Econ. 2017 Jan;18(1):73-82. IF2016: 2.500
Nesmerak K, Kudlacek K, Babica J. Analytical chemistry studying historical pharmaceuticals and health care formulations. A review. Monatsh Chem. 2017;148(9):1557-1568. IF2016: 1.282
Papastergiou J, Kheir N, Ladova K, Rydant S, De Rango F, Antoniou S, Viola R, Murillo MD, Steurbaut S, da Costa FA. Pharmacists' confidence when providing pharmaceutical care on anticoagulants, a multinational survey. Int J Clin Pharm. 2017 Dec;39(6):1282-1290. IF2016: 1.555
Straznicka J, Pokladnikova J, Jahodar L. Safety assessment of food additives in top-selling dietary supplements in the Czech Republic. Acta Pol Pharm. 2017;74(6):1929-1935. IF2016: 0.745
Vytrisalova M, Touskova T, Fuksa L, Karascak R, Palicka V, Byma S, Stepan J. How General Practitioners and Their Patients Adhere to Osteoporosis Management: A Follow-Up Survey among Czech General Practitioners. Front Pharmacol. 2017;8:258.
Zimcikova E, Simko J, Karesova I, Kremlacek J, Malakova J. Behavioral effects of antiepileptic drugs in rats: Are the effects on mood and behavior detectable in open-field test? Seizure-Eur J Epilep. 2017 Nov;52:35-40. IF2016: 2.448
2016
El Zowalaty ME, Belkina T, Bahashwan SA, El Zowalaty AE, Tebbens JD, Abdel-Salam HA, Khalil Al, Daghriry Sl, Gahtani MA, Madkhaly FM, Nohi Nl, Khodari RH, Sharahili RM, Dagreery KA, Khormi M, Habibah SA, Medrba BA, Gahtani AA, Hifthi RY, Zaid JM, Amshan AW, Alneami AA, Noreddin A, Vlcek J. Knowledge, awareness, and attitudes toward antibiotic use and antimicrobial resistance among Saudi population. Int J Clin Pharm. 2016 Oct;38(5):1261-8. IF2015: 1.339
Fialova D, Desplenter F. Aging of the Population, Clinical Pharmacy Services, and Interdisciplinary Cooperation in the Optimization of Pharmacotherapy in Older Patients. Drugs Aging. 2016 Mar;33(3):163-7. (editorial)
Pokladnikova J, Meyboom RH, Meincke R, Niedrig D, Russmann S. Allergy-Like Immediate Reactions with Herbal Medicines: A Retrospective Study Using Data from VigiBase(®). Drug Saf. 2016 May;39(5):455-64. IF2015: 3.206
Pokladnikova J, Selke-Krulichova I. Prevalence of Complementary and Alternative Medicine Use in the General Population in the Czech Republic. Forsch Komplementmed. 2016;23(1):22-8. IF2015: 0.551
Simko J, Karesova I, Kremlacek J, Fekete S, Zimcikova E, Malakova J, Zivna H, Valis M, Palicka V. The effect of lamotrigine and phenytoin on bone turnover and bone strength: A prospective study in Wistar rats. Epilepsy Res. 2016 Oct 24;128:113-118. IF2015: 2.237
Touskova T, Vytrisalova M, Palicka V, Hendrychova T, Chen YT, Fuksa L. Patterns of Non-adherence to Supplementation with Calcium and Vitamin D in Persistent Postmenopausal Women Are Similar at Start and 1 Year Later: A Qualitative Longitudinal Study. Front Pharmacol. 2016;7:339.
2015
Foebel A, Ballokova A, Wellens NI, Fialova D, Milisen K, Liperoti R, Hirdes JP. A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents. BMC Geriatr. 2015 Oct 19;15(1):128. IF2014: 1.676
Fuksa L, Vocelka M, Vytrisalova M. The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013. Health Policy. 2015;119(9):1255-64.
Fuksa L, Vytrisalova M. Adherence to denosumab in the treatment of osteoporosis and its utilization in the Czech Republic. Curr Med Res Opin. 2015;31(9):1645-53.
Hendrychova T, Vytrisalova M, Alwarafi A, Duintjer Tebbens J, Vankatova H, Leal S, Kubena AA, Smahelova A, Vlcek J. Fat- and fiber-related diet behavior among type 2 diabetes patients from distinct regions. Patient Prefer Adherence. 2015 Feb 19;9:319-25. IF2014: 1.676
Hromadkova L, Soukup T, Vlcek J. Quality of life and drug compliance: their interrelationship in rheumatic patients. J Eval Clin Pract. 2015 Jun 17. Oct;21(5):919-24. IF2014: 1.084
Kopecna E, Mica M, Vlcek J, Svoboda D. Use of medicines among students of high schools in the Czech Republic. Acta Pol Pharm. 2015 Mar;72(2):389-96. IF2014: 0.737
Kostriba J, Kotlarova J, Vlcek J. Opinions and Attitudes of Czech Citizens on Selected Issues of Drugs in Society. Acta Pol Pharm. 2015;72(5):1027-38. IF2014: 0.737
Machotka O, Manak J, Kubena A, Vlcek J. Incidence of intravenous drug incompatibilities in intensive care units. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Dec;159(4):652-6. IF2014: 1.200
Touskova T, Vytrisalova M, Palicka V, Hendrychova T, Fuksa L, Holcova R, Konopacova J, Kubena AA. Drug holidays: the most frequent type of noncompliance with calcium plus vitamin D supplementation in persistent patients with osteoporosis. Patient Prefer Adherence. 2015;9:1771-9.
Tsiantou V, Moschandreas J, Bertsias A, Papadakaki M, Saridaki A, Agius D, Alper Z, Faresjo T, Klimkova M, Martinez L, Samoutis G, Vlcek J, Lionis C. General Practitioners' intention to prescribe and prescribing patterns in selected European settings: The OTCSOCIOMED project. Health Policy. 2015 Sep;119(9):1265-74. IF2014: 1.907
Vytrisalova M, Touskova T, Ladova K, Fuksa L, Palicka V, Matoulkova P, Horak P, Stepan J. Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter. Climacteric. 2015;24:1-9. IF2014: 2.264
2014
Ballokova A, Peel NM, Fialova D, Scott IA, Gray LC, Hubbard RE. Use of benzodiazepines and association with falls in older people admitted to hospital: a prospective cohort study. Drugs Aging. 2014 Apr;31(4):299-310. IF2013:2.503
Belkina T, Al Warafi A, Hussein Eltom E, Tadjieva N, Kubena A, Vlcek J. Antibiotic use and knowledge in the community of Yemen, Saudi Arabia, and Uzbekistan. J Infect Dev Ctries. 2014 Apr 15;8(4):424-9. IF2013: 1.267
Belkina T, Khojiev D, Tillyashaykhov M, Tigay Z, Kudenov M, Tebbens J, Vlcek J. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study. BMC Infect Dis. 2014 Nov 25;14(1):624. IF2013: 2.561
Dosedel M, Maly J, Kubena A, Vlcek J. Opinions of Czech general practitioners on generic drugs and substitution. Cent Eur J Med. 2014 Dec; 9(6): 830-838. IF2013: 0.209
Dosedel M, Hendrychova T, Maly J, Kubena A, Byma S, Vlcek J. Prescription of evidence-based medicine drugs by general practitioners to patients after myocardial infarction: outcomes from the Czech republic. Acta Pol Pharm. 2014;71(1): 189-195. IF2013: 0.693
Fuksa L, Vytrisalova M, Hendrychova T, Hrubesova I, Vlcek J, Palicka V. Consumption of osteoanabolic drugs and strontium ranelate in the treatment of osteoporosis in the Czech Republic in 2005-2011. Acta Pol Pharm. 2014;71(2):329-35.
Gindin J, Shochat T, Chetrit A, Epstein S, Ben Israel Y, Levi S, Onder G, Carpenter I, Finne-Soveri H, van Hout H, Henrard JC, Nikolaus T, Topinkova E, Fialova D, Bernabei R; SHELTER project. Insomnia in long-term care facilities: a comparison of seven European countries and Israel: the Services and Health for Elderly in Long TERm care study. J Am Geriatr Soc. 2014 Nov;62(11):2033-9. IF2013: 4.572
Kalafutova S, Juraskova B, Vlcek J. The Impact of Combinations of Non-Steroidal Anti-Inflammatory Drugs and Anti-Hypertensive Agents on Blood Pressure. Adv Clin Exp Med 2014;23(6):993-1000. IF2013: 0.333
Kostriba J, Alwarafi A, Vlcek J. Social Pharmacy as a Field of Study in Undergraduate Pharmacy Education. Indian J Pharm Educ Res. 2014;48(1):6-12. IF2013: 0.219
Ladova K, Matoulkova P, Zadak Z, Macek K, Vyroubal P, Vlcek J, Morisky DE. Self-reported adherence by MARS-CZ reflects LDL cholesterol goal achievement among statin users: validation study in the Czech Republic. J Eval Clin Pract. 2014 Oct;20(5):671-7. IF2013: 1.580
Ladova K, Vlcek J, Vytrisalova M, Maly J. Healthy adherer effect – the pitfall in the interpretation of the effect of medication adherence on health outcomes. J Eval Clin Pract. 2014 Apr;20(2):111-6. IF2013: 1.580
Lionis C, Petelos E, Shea S, Bagiartaki G, Tsiligianni IG, Kamekis A, Tsiantou V, Papadakaki M, Tatsioni A, Moschandreas J, Saridaki A, Bertsias A, Faresjö T, Faresjö A, Martinez L, Agius D, Uncu Y, Samoutis G, Vlcek J, Abasaeed A, Merkouris B. Irrational prescribing of over-the-counter (OTC) medicines in general practice: Testing the feasibility of an educational intervention among physicians in five European countries. BMC Fam Pract. 2014 Feb 17;15:34. IF2013: 1.735
Matoulkova P, Pavek P, Maly J, Vlcek J. Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction. Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):425-35. IF2013: 2.934
Pipalova R, Vlcek J, Slezak R. The trends in antibiotic use by general dental practitioners in the Czech Republic (2006-2012). Int Dent J. 2014 Jun;64(3):138-43. IF2013: 1.195
Vytrisalova M, Fuksa L, Palicka V, Byma S, Blazkova S, Stepan J, Hendrychova T, Vlcek J, Pavek P. Aherence to osteoporosis guideline: survey among Czech general practitioners. Cent Eur J Med. 2014;9:687-93.
2013
Abasaeed AE, Vlcek J, Abuelkhair MA, Andrajati R, Elnour AA. A comparative study between prescribed and over-the-counter antibiotics. Saudi Med J. 2013 Oct;34(10):1048-54. IF2013: 0.554
Hendrychova T, Vytrisalova M, Vlcek J, Smahelova A, Kubena AA. An analysis of fat-related and fiber-related behavior in men and women with type 2 diabetes mellitus: key findings for clinical practice. Patient Prefer Adherence. 2013 Sep 3;7:877-84. IF2013: 1.491
Hendrychova T, Vytrisalova M, Smahelova A, Vlcek J, Kubena AA. Adherence in adults with type 1 diabetes mellitus correlates with treatment satisfaction but not with adverse events. Patient Prefer Adherence. 2013 Sep 2;7:867-76. IF2013: 1.491
Lukas A, Mayer B, Fialova D, Topinkova E, Gindin J, Onder G, Bernabei R, Nikolaus T, Denkinger MD. Treatment of pain in European nursing homes: results from the Services and Health for Elderly in Long TERm Care (SHELTER) study. J Am Med Dir Assoc. 2013 Nov;14(11):821-31. IF2013: 4.446
Lukas A, Mayer B, Fialova D, Topinkova E, Gindin J, Onder G, Bernabei R, Nikolaus T, Denkinger MD.Pain characteristics and pain control in European nursing homes: cross-sectional and longitudinal results from the Services and Health for Elderly in Long TERm care (SHELTER) study. J Am Med Dir Assoc. 2013 Jun;14(6):421-8. IF2013: 4.446
Maly J, Dosedel M, Kubena A, Vlcek J. Analysis of pharmacists’ opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic. Acta Pol Pharm. 2013;70(5):923-31. IF2013: 0.693
Matoulkova P, Dosedel M, Ruzkova B, Kubena A. Information and awareness concerning ibuprofen as an ingredient in over the counter analgesics: a questionnaire-based survey of residents of retirement communities. Acta Pol Pharm. 2013;70(2):333-8. IF2013: 0.693
Matoulkova P, Krulichova IS, Macek K, Vlcek J, Bastecka D, Prixova M, Horne R. Chronically ill Czech patients' beliefs about medicines: The psychometric properties and factor structure of the BMQ-CZ. Ther Innov Regul ScI. 2013;47(3):341-8. IF2013: 0.545
Onder G, Liperoti R, Foebel A, Fialova D, Topinkova E, van der Roest HG, Gindin J, Cruz-Jentoft AJ, Fini M, Gambassi G, Bernabei R; SHELTER project. Polypharmacy and mortality among nursing home residents with advanced cognitive impairment: results from the SHELTER study. J Am Med Dir Assoc. 2013 Jun;14(6):450.e7-12. IF2013: 4.446
Petrikova A, Dolezal T, Klimes J, Vocelka M, Sedova L, Kolar J. The economic burden of the ankylosing spondylitis in the Czech Republic: comparison between 2005 and 2008. Rheumatol Int. 2013 Jul;33(7):1813-9. IF2013: 1.627
Pokladnikova J, Selke-Krulichova I. Effectiveness of a comprehensive lifestyle modification program for asthma patients: a randomized controlled pilot trial J Asthma. 2013 Apr;50(3):318-26. IF2013: 1.828
Vetrano DL, Tosato M, Colloca G, Topinkova E, Fialova D, et al.; SHELTER Study. Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study. Alzheimers Dement. 2013; 9(5): 587-93 IF2013: 19.764
Zadak Z, Hyspler R, Ticha A, Vlcek J. Polypharmacy and malnutrition. Curr Opin Clin Nutr Metab Care. 2013 Jan;16(1):50-5. IF2013: 4.522
2012
Bartas R, Kolar J, Ambrus T, Lazauskas R, Bernatoniene J, Peciura R. Utilization of lipid modifying agents in the Karvina district: A comparison with the Czech Republic, 2002 to 2009. Afric J Pharm Pharmacol. 2012;6(12):924-33. IF2011: 0.839
Colloca G, Tosato M, Vetrano DL, Topinkova E, Fialova D, Gindin J, van der Roest HG, Landi F, Liperoti R, Bernabei R, Onder G; SHELTER project. Inappropriate drugs in elderly patients with severe cognitive impairment: results from the shelter study. PLoS One. 2012;7(10):e46669. IF2012: 4.697
Hromadkova L, Soukup T, Cermakova E, Vlcek J. Drug compliance in patients with systemic scleroderma. Clin Rheumatol. 2012 Nov;31(11):1577-83. IF2012: 2.037
Hromadkova L, Soukup T, Vlcek J. Important drug interactions in patients with rheumatic disorders: interactions of glucocorticoids, immunosuppressants and antimalarial drugs. Drugs Today (Barc). 2012 Aug;48(8):545-53. IF2012: 1.215
Krnacova V, Kubena A, Macek K, Bezdek M, Smahelova A, Vlcek J. Severe hypoglycaemia requiring the assistance of emergency medical services--frequency, causes and symptoms. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2012 Sep;156(3):271-7. IF2012: 0.990
Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F; SHELTER Project. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012 Jun;67(6):698-704. IF2012: 4.314
Pipalova R, Vlcek J, Matoulkova P. The evaluation of antibiotic prescribing in general practice using a health insurance company database: penicillins use. Croat Med J. 2012 Oct;53(5):505-6. IF2012: 1.250
Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012 Jun 1;29(6):495-510. IF2012: 2.646
Srba J, Descikova V, Vlcek J. Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009. Eur J Clin Pharmacol. 2012 Jul;68(7):1057-63. IF2012: 2.741
Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H, Metz-Gercek S, Jansens H, Markova B, Kontemeniotou C, Andrasevic A, Vlcek J, et al. Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009. Clin Microbiol Infect. 2012 Oct;18(10):E389-95. IF2012: 4.749
2011
Adriaenssens N, Coenen S, Versporten A, Muller A, Vankerckhoven V, Goossens H, Mittermayer H, Metz S, Fluch G, Vaerenberg S, Goossens MM, Markova B, Andrašević AT, Kontemeniotis A, Vlcek J, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi71-77. IF2011: 5.068
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H, Mittermayer H, Metz S, Fluch G, Vaerenberg S, Goossens MM, Markova B, Andrašević AT, Kontemeniotis A, Vlcek J, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi47-56. IF2011: 5.068
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H, Mittermayer H, Metz S, Fluch G, Vaerenberg S, Goossens MM, Markova B, Andrašević AT, Kontemeniotis A, Vlcek J, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi37-45. IF2011: 5.068
Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H, Mittermayer H, Metz S, Fluch G, Vaerenberg S, Goossens MM, Markova B, Andrašević AT, Kontemeniotis A, Vlcek J, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi3-12. IF2011: 5.068
Coenen S, Adriaenssens N, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H, Mittermayer H, Metz S, Fluch G, Vaerenberg S, Goossens MM, Markova B, Andrašević AT, Kontemeniotis A, Vlcek J, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient use of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi57-70. IF2011: 5.068
Versporten A, Coenen S, Adriaenssens N, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H, Mittermayer H, Metz S, Fluch G, Vaerenberg S, Goossens MM, Markova B, Andrašević AT, Kontemeniotis A, Vlcek J, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi25-35. IF2011: 5.068
Versporten A, Coenen S, Adriaenssens N, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H, Mittermayer H, Metz S, Fluch G, Vaerenberg S, Goossens MM, Markova B, Andrašević AT, Kontemeniotis A, Vlcek J, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009). J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi13-23. IF2011: 5.068
Kopecna E, Descikova V, Vlcek J, Mlada J. Adverse drug reaction reporting in the Czech Republic 2005-2009. Int J Clin Pharm. 2011;33(4):683-9. IF2011: 1.215
Until 2010
Abasaeed A, Vlcek J, Abuelkhair M, Kubena A. Self-medication with antibiotics by the community of Abu Dhabi Emirate, United Arab Emirates. J Infect Dev Ctries. 2009 Aug 30;3(7):491-7.
Agrawal A, Aronson JK, Britten N, Ferner RE, de Smet PA, Fialová D, Fitzgerald RJ, Likić R, Maxwell SR, Meyboom RH, Minuz P, Onder G, Schachter M, Velo G. Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol. 2009 Jun;67(6):592-8.
Andrajati R, Vlcek J, Kolar M, Pípalová R. Survey of surgical antimicrobial prophylaxis in czech republic. Pharm World Sci. 2005 Dec;27(6):436-41.
Ayalon L, Fialová D, Areán PA, Onder G. Challenges associated with the recognition and treatment of depression in older recipients of home care services. Int Psychogeriatr. 2010 Jun;22(4):514-22.
Blazkova S, Vytrisalova M, Palicka V, Stepan J, Byma S, Kubena AA, Hala T, Vlcek J. Osteoporosis risk assessment and management in primary care: focus on quantity and quality. J Eval Clin Pract. 2010;16(6):1176-82.
Fialová D, Onder G. Medication errors in elderly people: contributing factors and future perspectives. Br J Clin Pharmacol. 2009 Jun;67(6):641-5.
Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M, Onder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R; AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005 Mar 16;293(11):1348-58.
Catananti C, Liperoti R, Settanni S, Lattanzio F, Bernabei R, Fialova D, Landi F, Onder G. Heart failure and adverse drug reactions among hospitalized older adults. Clin Pharmacol Ther. 2009 Sep;86(3):307-10.
Cerveny P, Bortlik M, Vlcek J, Kubena A, Lukás M. Non-adherence to treatment in inflammatory bowel disease in Czech Republic. J Crohns Colitis. 2007 Dec;1(2):77-81.
Cervený P, Bortlík M, Kubena A, Vlcek J, Lakatos PL, Lukás M. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis. 2007 Oct;13(10):1244-9.
Cooper C, Carpenter I, Katona C, Schroll M, Wagner C, Fialova D, Livingston G. The AdHOC Study of older adults' adherence to medication in 11 countries. Am J Geriatr Psychiatry. 2005 Dec;13(12):1067-76.
Gorecka K, Linhartova A, Vlcek J,Tilser I. Cardiovascular drug utilisation and socio-economic inequalities in 20 districts of the Czech Republic. Eur J Clin Pharmacol. 2005;61(5-6):417-23.
Jindrak V, Marek J, Vanis V, Urbaskova P, Vlcek J, Janiga L, Maresova V. Improvements in antibiotic prescribing by community paediatricians in the Czech Republic.Euro Surveill. 2008 Nov 13;13(46). pii: 19040.
Kucera Z, Vlcek J, Hejdova M. Theoretical exposure of chronically treated patients to lipid lowering agents. Pharmacoepidemiol Drug Saf. 2005 Jan;14(1):61-7.
Mach R, Vlcek J, Prusova M, Batka P, Rysavy V, Kubena A. Impact of a multidisciplinary approach on antibiotic consumption, cost and microbial resistance in a Czech hospital. Pharm World Sci. 2007 Oct;29(5):565-72.
Pokladnikova J, Meyboom RH, Vlcek J, Edwards RI. Can intranasal corticosteroids cause migraine-like headache? Cephalalgia. 2009;29:360-4.
Pokladnikova J, Meyboom RH, Vlcek J, Edwards RI. Intranasally administered corticosteroids and neuropsychiatric disturbances: a review of the international pharmacovigilance programme of the World Health Organization. Ann Allergy Asthma Immunol. 2008;101(1):67-73.
Pokladnikova J, Krcmova I, Vlcek J. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol. 2008;100(5):482-9.
Pokladnikova J, Lie D. Comparison of attitudes, beliefs, and resource-seeking behavior for CAM among first- and third-year Czech pharmacy students. Am J Pharm Educ. 2008;72(2):24.
Soldato M, Liperoti R, Landi F, Finne-Sovery H, Carpenter I, Fialova D, Bernabei R, Onder G. Non malignant daily pain and risk of disability among older adults in home care in Europe. Pain. 2007 Jun;129(3):304-10.
Sørbye LW, Garms-Homolová V, Henrard JC, Jónsson PV, Fialová D, Topinková E, Gambassi G. Shaping home care in Europe: the contribution of the Aged in Home Care project. Maturitas. 2009 Mar 20;62(3):235-42.
Tlusta E, Zarubova J, Simko J, Hojdikova H, Salek S, Vlcek J. Clinical and demographic characteristics predicting QOL in patients with epilepsy in the Czech Republic: how this can influence practice. Seizure. 2009 Mar;18(2):85-9.
Tlusta E, Handoko KB, Majoie M, Egberts TC, Vlcek J, Heerdink ER.Clinical relevance of patients with epilepsy included in clinical trials. Epilepsia. 2008 Aug;49(8):1479-80.
Tlusta E, Zarubova J, Simko J, Hojdikova H, Vlcek J. Pharmacoepidemiological study of 427 patients with epilepsy. Cesk Slov Neurol N. 2008;71(6):682-7.
Tlusta E, Kubena A, Salek S, Vlcek J. Psychometric properties of the Czech version of the Quality of Life in Epilepsy Inventory (QOLIE-31). Epilepsy Behav. 2007 May;10(3):407-11.
Vokata V, Odrazka K, Kubena A, Vlcek J. Bisphosphonates for bone metastatic disease from breast cancer: clinical practice in the Czech Republic. Clin Exp Metastasis. 2008;25(4):371-6.
Vytrisalova M, Blazkova S, Palicka V, Vlcek J, Cejkova M, Hala T, Pavelka K, Koblihova H. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates. Maturitas. 2008;60(3-4):223-9.
Vytrisalova M, Kubena AA, Vlcek J, Palicka V, Hala T, Pavelka K. Knowledge of osteoporosis correlated with hormone therapy use and health status. Maturitas. 2007;56(1):21-9.